Researchers from the Babraham Institute, UK, and the German Center for Neurodegenerative Diseases (DZNE) have identified a backup mechanism of protein quality control which prevents the toxic effects of protein aggregation in specific tissues when normal methods of molecular monitoring fail.
Zimmer, RevelAi partner to sell AI tool for orthopedic care
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Zimmer Biomet has partnered with